References

  1. Hau T, Simmons RL: Heparin in the treatment of experimental peritonitis.

    Ann Surg 1978, 187:294-298. PubMed Abstract OpenURL

  2. Chalkiadakis G, Kostakis A, Karayannacos PE, Giamarellou H, Dontas I, Sakellariou I, Skalkeas GD: The effect of heparin upon fibrinopurulent peritonitis in rats.

    Surg Gynecol Obstet 1983, 157:257-260. PubMed Abstract OpenURL

  3. Emerson TE Jr, Fournel MA, Redens TB, Taylor FB Jr: Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.

    Am J Med 1989, 87(suppl B):27S-33S. Publisher Full Text OpenURL

  4. Triantaphyllopoulos DC: Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin.

    Thromb Haemost 1984, 51:232-235. PubMed Abstract OpenURL

  5. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

    Circ Shock 1991, 33:127-134. PubMed Abstract OpenURL

  6. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

    J Clin Invest 1994, 93:114-120. PubMed Abstract | PubMed Central Full Text OpenURL

  7. Dackiw AP, McGilvray ID, Woodside M, Mathens AB, Marshall JC, Rotstein OD: Prevention of endotoxin-induced mortality by anti-tissue factor immunization.

    Arch Surg 1996, 131:1273-1278. PubMed Abstract OpenURL

  8. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

    J Clin Invest 1987, 79:918-925. PubMed Abstract | PubMed Central Full Text OpenURL

  9. Powars D, Larsen R, Johnson J, Hulbert T, Sun T, Patch MJ, Francis R, Chan L: Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.

    J Infect Dis 1993, 17:254-261. OpenURL

  10. Hemmer CJ, Kern P, Holst FG, Radtke KP, Egbring R, Bierhaus A, Nawroth PP, Dietrich M: Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels.

    Am J Med 1991, 91:37-44. PubMed Abstract | Publisher Full Text OpenURL

  11. Haire WD, Ruby EI, Gordon BG, Patil KD, Stephens LC, Kotulak GD, Reed EC, Vose JM, Bierman PJ, Kessenger A, et al.: Multiple organ dysfunction syndrome in bone marrow transplantation.

    J Am Med Assoc 1995, 274:1289-1295. Publisher Full Text OpenURL

  12. Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR: Low levels of protein C are associated with poor outcome in severe sepsis: acquired protein C deficiency state in sepsis.

    Crit Care Med 2001, in press. OpenURL

  13. Kalter ES, van Dijk WC, Timmerman A, Verhoef J, Bouma BN: Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.

    J Infect Dis 1983, 4:682-691. OpenURL

  14. Molla A, Yamamoto T, Akaike T, Miyoshi S, Maeda H: Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases.

    J Biol Chem 1989, 264:10589-10594. PubMed Abstract | Publisher Full Text OpenURL

  15. Mavrommatis AC, Theodoridis T, Orfanidoui A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S: Coagulation system and platelets are fully activated in uncomplicated sepsis.

    Crit Care Med 2000, 28:451-457. PubMed Abstract | Publisher Full Text OpenURL

  16. Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S: Changes of the hemostatic network in critically ill patients: is there a difference between sepsis, trauma, and neurosurgery patients?

    Crit Care Med 2000, 28:445-450. PubMed Abstract | Publisher Full Text OpenURL

  17. Günther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D: Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome.

    Am J Respir Crit Care Med 2000, 161:454-462. PubMed Abstract | Publisher Full Text OpenURL

  18. Fourrier F, Chopin C, Goudemand J, Hendryex S, Caron C, Rime A, Marey A, Lestavel P: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.

    Chest 1992, 101:816-823. PubMed Abstract OpenURL

  19. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruin-ing H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.

    Intensive Care Med 1996, 22:707-710. PubMed Abstract | Publisher Full Text OpenURL

  20. Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, Risseeuw-Appel IM, van der Voort E, de Groot R: The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.

    J Infect Dis 1996, 173:1148-1156. PubMed Abstract OpenURL

  21. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J: Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.

    Chest 1993, 104:882-888. PubMed Abstract OpenURL

  22. Fourrier F, Jourdain M, Tournoys A: Clinical trial results with antithrombin III in sepsis.

    Crit Care Med 2000, 28(9 suppl):S38-S43. Publisher Full Text OpenURL